Trufill Dcs Orbit Detachable Coil and Trufill Dcs Syringe or Trufill Dcs Syringe II Also Known as the Trufill Dcs Orbit
Cordis Neurovascular
Product: Trufill — all models and sizes
FDA Clearance Information
The Trufill DCS Orbit Detachable Coil, manufactured by Cordis Neurovascular, received FDA clearance via the 510(k) pathway on May 2, 2008. It is classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Endovascular embolization of cerebral aneurysms.
- Use in the neurovascular circulation when detachable coil embolization is indicated.
Clinical Applications
- Endovascular coil embolization of intracranial cerebral aneurysms.
- Treatment of selected ruptured cerebral aneurysms after subarachnoid hemorrhage.
- Treatment of selected unruptured cerebral aneurysms.
- Filling and occluding an aneurysm sac to reduce blood flow and the risk of aneurysm rupture or rebleeding.
Reported off-label uses
- Embolization of selected nonaneurysmal intracranial vascular lesions may be reported in clinical practice, but this is not necessarily covered by the device labeling and requires case-specific specialist judgment.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The system includes a detachable platinum coil and a compatible delivery or detachment syringe system; compatibility should be confirmed before the procedure.
- Coil dimensions and shape are selected according to the aneurysm's size, neck, location, and the parent vessel anatomy.
- The device is delivered through a microcatheter under fluoroscopic or digital subtraction angiographic guidance, typically with local anesthesia and conscious sedation or general anesthesia depending on the case.
- MRI safety and conditional-use requirements depend on the exact device labeling and implanted coil configuration; the current manufacturer instructions should be reviewed before MRI.
- Contraindications and precautions include unsuitable vascular anatomy, inability to safely catheterize the target vessel, active infection, severe contrast allergy, and conditions that prevent anticoagulation or procedural imaging when these are clinically required.
Linked Studies (9)
Middle Meningeal Artery Embolization with n-Butyl Cyanoacrylate for the Treatment of Subdural Hematomas: The MEMBRANE Study Design.
Stroke (Hoboken, N.J.)
RCT|prospective|retrospective|case Series|other View Source →Comparison of Cost and Efficacy of Trufill® vs Histoacryl® n-Butyl Cyanoacrylate for Translumbar Type 2 Endoleak Embolization.
Vascular and endovascular surgery
RCT|prospective|retrospective|case Series|other View Source →ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.
Journal of neurointerventional surgery
RCT|prospective|retrospective|case Series|other View Source →Complex shaped detachable platinum coil system for the treatment of cerebral aneurysms: the Codman Trufill DCS and Trufill DCS Orbit Detachable Coil System COMPLEX Registry final results.
Journal of neurointerventional surgery
RCT|prospective|retrospective|case Series|other View Source →Initial Clinical Experience with a New Complex-Shaped Detachable Platinum Coil System for the Treatment of Intracranial Cerebral Aneurysms. The Cordis Trufill DCS Detachable Coil System.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →Midterm clinical experience with a complex-shaped detachable platinum coil system for the treatment of cerebral aneurysms: Trufill DCS Orbit detachable coil system registry interim results.
Journal of vascular and interventional radiology : JVIR
RCT|prospective|retrospective|case Series|other View Source →Combined use of TruFill DCS detachable coil system and Guglielmi detachable coil for embolization of meningioma fed by branches of the cavernous internal carotid artery.
Neurologia medico-chirurgica
View Source →N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial.
AJNR. American journal of neuroradiology
RCT|prospective|retrospective|case Series|other View Source →Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA
View Source →Frequently Asked Questions
What are the clinical indications for Trufill DCS Orbit Detachable Coil?
The device is indicated for the embolization of cerebral aneurysms, providing an endovascular option for aneurysm occlusion.
What outcomes have been reported in clinical studies?
Studies have reported effective aneurysmal occlusion and stability of occlusion over midterm follow-up periods.
What complications have been reported?
Safety data indicate risks of thromboembolic events and coil migration, consistent with endovascular procedures.